Early Onset and Triple Negative Breast Cancer Study

I’m participating in a long-term breast cancer gene study being conducted by the King Laboratory at the University of Washington.  I only have to provide blood - a collection kit arrived via Fed Ex last week.

And since having blood withdrawn is a common occurrence for me these days, why wouldn’t I?  I’ll take the kit with me the next time I go to the lab at Emory’s infusion center.

Criteria for the study follows:

  • Individuals with invasive breast cancer diagnosed at age 40 or younger, regardless of family history, OR triple negative invasive breast cancer diagnosed at any age, regardless of family history,
  • Prior commercial testing for BRCA1 and BRCA2, regardless of results of that testing

I was diagnosed at 41, but I’m triple negative and I’ve been tested for BRCA1 and BRCA2 mutations.  Those test results were negative, but that could be because the commercial tests don’t account for all of the changes that can cause cancer.  Or there could be a different gene involved – apparently, there are over 20 other known “breast cancer genes.”  It’s also possible that my cancer has nothing to do with genetics.

But knowledge is power.  So, Smart-People-Working-To-Find-More-Effective-Treatment-For-Cancer, you are welcome to my blood.  Test away.  And, thank you.

Everybody else, if you’re interested, click below for a PDF file of a summary of the study.  It’s posted here with permission.  And, certainly, pass it on if you know someone else who qualifies.
GENOMIC ANALYSIS OF INHERITED BREAST CANCER AMONG WOMEN DIAGNOSED WITH TRIPLE-NEGATIVE DISEASE OR WITH DIAGNOSIS AT AGE 40 OR YOUNGER

Nicole

Comments

  1. Thank you for all you do to help the research community and all of us.

  2. Christine says:

    I ditto Aunt Edna!

  3. Bless your heart. You are so informative. What great lady you are. Hugs and love.